Skip to main content
. 2019 Jan 7;2019(1):CD009841. doi: 10.1002/14651858.CD009841.pub3

2.1. Analysis.

2.1

Comparison 2 Ivacaftor (VX‐770) versus placebo in people with at least one G551D CFTR mutation, Outcome 1 CFQ‐R score (respiratory domain, child version) ‐ adjusted change from baseline.